Nov 04, 2025 • Zacks Commentary
NEUTRAL
PROCEPT BioRobotics Corporation ( PRCT ) Reports Q3 Loss, Beats Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +7.32% and +3.35%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 30, 2025 • Zacks Commentary
NEUTRAL
Mettler-Toledo ( MTD ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 29, 2025 • Motley Fool
BULLISH
2 Robotics Stocks Riding the Sensor and Medical Boom
The robotics infrastructure layer is delivering explosive returns.
Oct 28, 2025 • Zacks Commentary
NEUTRAL
Earnings Preview: PROCEPT BioRobotics Corporation ( PRCT ) Q3 Earnings Expected to Decline
PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 24, 2025 • Motley Fool
SOMEWHAT-BULLISH
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?
According to a filing with the U.S. Securities and Exchange Commission dated October 22, 2025, investment company Chicago Capital, LLC increased its position in Procept BioRobotics ( NASDAQ:PRCT ) by 999,873 shares, bringing its total holdings to 1,568,845 shares, valued at $55.99 million at ...
Oct 20, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval
STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.